Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial

BACKGROUND: BCG vaccine may reduce overall mortality by increasing resistance to nontuberculosis infections. In 2 randomized trials in Guinea-Bissau of early BCG-Denmark (Statens Serum Institut) given to low-weight (LW) neonates (<2500 g at inclusion) to reduce infant mortality rates, we observed...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Infect Dis
Huvudupphovsmän: Biering-Sørensen, Sofie, Aaby, Peter, Lund, Najaaraq, Monteiro, Ivan, Jensen, Kristoffer Jarlov, Eriksen, Helle Brander, Schaltz-Buchholzer, Frederik, Jørgensen, Anne Sofie Pinstrup, Rodrigues, Amabelia, Fisker, Ane Bærent, Benn, Christine Stabell
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2017
Ämnen:
Articles and Commentaries
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5849087/
https://ncbi.nlm.nih.gov/pubmed/29579158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix525
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk